Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Boyer

Showing results (261-270 of 428) with videos related to

Pageof 43
Sort By:
Eye (London, England)|May 28, 2024
ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathyQuan Dong Nguyen, Justis P Ehlers, David S Boyer, et al.
BMJ Open Ophthalmology|February 3, 2026
Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a studySunil S Patel, David S Boyer, Anat Loewenstein, et al.
Medecine Et Maladies Infectieuses|October 24, 2019
Lack of effect of a poster-based intervention to reduce the number of blood culture samples collectedL Boulet, T Vermeulin, A Vasiliu, et al.
Ophthalmology|February 3, 2007
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationDavid S Boyer, Andrew N Antoszyk, Carl C Awh, et al.
Translational Vision Science & Technology|March 28, 2023
Sustained Ocular Delivery of Bevacizumab Using Densomeres in Rabbits: Effects on Molecular Integrity and BioactivityJan S Peterson, WeiLiam Chen, Barry M Libin, et al.
Current Eye Research|July 21, 2004
Efficacy of verteporfin photodynamic therapy on laser-induced choroidal neovascularization and the ancillary effect on diabetic microvasculopathyMehryar Taban, Edgar L Thomas, David S Boyer, et al.
Journal of Diabetes Science and Technology|February 11, 2010
Antisense oligonucleotide therapy in diabetic retinopathyPeter Hnik, David S Boyer, Lisa R Grillone, et al.
Ophthalmology|August 1, 2009
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degenerationDavid S Boyer, Jeffrey S Heier, David M Brown, et al.
BMJ Open|March 16, 2018
Protocol for the economic evaluation of a complex intervention to improve the mental health of maltreated infants and children in foster care in the UK (The BeST? services trial)Manuela Deidda, Kathleen Anne Boyd, Helen Minnis, et al.
Retina (Philadelphia, Pa.)|September 23, 2024
ReplyDavid S Boyer, Marion R Munk, Stephanie E Tedford, et al.
Pageof 43

Showing results (261-270 of 428) with videos related to

Sort By:
Pageof 43
Eye (London, England)|May 28, 2024
ROBIN: a randomised, double-masked, placebo-controlled Phase IIa study of the AOC3 inhibitor BI 1467335 in diabetic retinopathyQuan Dong Nguyen, Justis P Ehlers, David S Boyer, et al.
BMJ Open Ophthalmology|February 3, 2026
Safety and tolerability of avacincaptad pegol in combination with ranibizumab in treatment-naïve patients with neovascular age-related macular degeneration: results from a phase 1 and phase 2a studySunil S Patel, David S Boyer, Anat Loewenstein, et al.
Medecine Et Maladies Infectieuses|October 24, 2019
Lack of effect of a poster-based intervention to reduce the number of blood culture samples collectedL Boulet, T Vermeulin, A Vasiliu, et al.
Ophthalmology|February 3, 2007
Subgroup analysis of the MARINA study of ranibizumab in neovascular age-related macular degenerationDavid S Boyer, Andrew N Antoszyk, Carl C Awh, et al.
Translational Vision Science & Technology|March 28, 2023
Sustained Ocular Delivery of Bevacizumab Using Densomeres in Rabbits: Effects on Molecular Integrity and BioactivityJan S Peterson, WeiLiam Chen, Barry M Libin, et al.
Current Eye Research|July 21, 2004
Efficacy of verteporfin photodynamic therapy on laser-induced choroidal neovascularization and the ancillary effect on diabetic microvasculopathyMehryar Taban, Edgar L Thomas, David S Boyer, et al.
Journal of Diabetes Science and Technology|February 11, 2010
Antisense oligonucleotide therapy in diabetic retinopathyPeter Hnik, David S Boyer, Lisa R Grillone, et al.
Ophthalmology|August 1, 2009
A Phase IIIb study to evaluate the safety of ranibizumab in subjects with neovascular age-related macular degenerationDavid S Boyer, Jeffrey S Heier, David M Brown, et al.
BMJ Open|March 16, 2018
Protocol for the economic evaluation of a complex intervention to improve the mental health of maltreated infants and children in foster care in the UK (The BeST? services trial)Manuela Deidda, Kathleen Anne Boyd, Helen Minnis, et al.
Retina (Philadelphia, Pa.)|September 23, 2024
ReplyDavid S Boyer, Marion R Munk, Stephanie E Tedford, et al.
Pageof 43